Outpatient Facility Coding Alert - 2008 Issue 25
READER QUESTION: Learn Foolproof Drug Wastage Calculation
Subscribe or sign in to view the full article.
Article Overview
This reader Q&A discusses CMS guidance on handling drug wastage in billing. It covers how waste is calculated in a general sense for single-dose vial situations, notes a sample oncology drug scenario, and references the JW modifier and CMS claim-processing guidance. The article is relevant to coders, billing staff, and oncology practices that need to understand wastage-related claim reporting.
Why This Topic Matters
Drug wastage reporting affects claim accuracy and compliance, especially for practices that bill injectable drugs and biologicals. Understanding the general CMS framework and related modifier usage helps reduce billing errors and supports proper claim submission.
Article Sections
-
Question
A reader asks about calculating drug wastage and avoiding common errors in billing situations involving injectable drugs.
-
Answer
The response summarizes a general approach to calculating waste for single-dose vial drugs and discusses related reporting considerations.
-
Example
A sample oncology drug scenario is used to illustrate the calculation process in a billing context.
-
Experts note
A CMS-related note addresses how remaining amounts are associated when a single-dose vial is used across more than one patient.
-
Remember
The article reinforces a billing distinction related to single-patient use of a vial.
-
Warning
A caution is provided about reporting waste in certain vial settings.
-
For more info
Source attribution is given for the example and presentation context.
-
Bonus
The article introduces a related billing modifier and places it in the context of CMS claim-processing guidance.
-
According to CMS
A CMS quotation describes when the modifier may be required for unused drug or biological amounts from single-use containers.
-
You can find more information
A final reference points readers to additional CMS claim-processing documentation on drug wastage.
What You Will Learn
- How the article frames CMS guidance on drug wastage reporting
- How a general wastage calculation is presented in a billing context
- What role CMS guidance plays in reporting discarded drug amounts
- What related billing modifier is mentioned in connection with discarded drug reporting
- Where the article directs readers for additional CMS information
Who Should Read This
- Medical coders
- Billing staff
- Oncology practices
- Revenue cycle professionals
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.



Quick, Current, Complete - www.findacode.com